IL10 and infection: Although IL‐10 therapy does not impact monocyte/macrophage and neutrophil phagocytic ability or the production of reactive oxygen species (suggesting the retention of key innate immune functions (Schwab, Wyatt, Nelson, et al., 2024)), future studies to understand its role in infection would inform whether antimicrobial prophylaxis would be required for translational application.